Determination of Delta-aminolevulinic Acid in Plasma using High-performance Liquid Chromatography: A Sensitive Indicator of Lead Effects

We developed a simple and reliable method for determining delta-aminolevulinic acid (ALA) in plasma (ALA-P) by fluorometric high-performance liquid chromatography. The method was applicable to 100 μl of plasma and the mean ± standard deviation for analytical recovery was 100.4 ± 2.6% when 50 pg/1 of...

Full description

Saved in:
Bibliographic Details
Published inIndustrial Health Vol. 32; no. 2; pp. 85 - 96
Main Authors MORITA, Yoko, ARAKI, Shunichi, SAKAI, Tadashi, ARAKI, Takaharu, MASUYAMA, Yoshiaki
Format Journal Article
LanguageEnglish
Published Japan National Institute of Occupational Safety and Health 1994
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We developed a simple and reliable method for determining delta-aminolevulinic acid (ALA) in plasma (ALA-P) by fluorometric high-performance liquid chromatography. The method was applicable to 100 μl of plasma and the mean ± standard deviation for analytical recovery was 100.4 ± 2.6% when 50 pg/1 of ALA was added to 14 plasma samples. The detection limit for ALA-P was 2.0 μg/l (signal-to-noise ratio was 5) and the standard curve was linear in a wide range up to 400 μg/l. The ALA-P level for 26 unexposed male adults was 8.6 ± 1.3 μg/l. In 72 male lead workers, logarithm of ALA-P concentration was significantly correlated with blood lead concentrations (Pb-B) of 2.5-115.4 μg/dl (r = 0.924, p < 0.001). Even at the Pb-B level less than 15 pg/dl, significant linear relationships were found between Pb-B and log ALA-P (r = 0.632, p < 0.01), between Pb-B and delta-aminolevulinic acid dehydratase activity (ALA-D) (r =-0.573, p < 0.05), and between ALA-D and ALA-P (r =-0.765, p < 0.001). It is suggested that ALA-P determined by the present method is a useful indicator of biological effects of lead, es-pecially in the wide range of Pb-B level.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0019-8366
1880-8026
DOI:10.2486/indhealth.32.85